[1]Hromadnikova I, Kotlabova K, Hympanova L, et al. Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood.[J]. Thromb Res, 2016, 137:126-140.
[2]Liao YX, Wang ChH. The application of magnesium sulfate and antihypertensive drugs for hypertensive disorder complicating pregnancy[J]. Chinese Journal of Family Planning & Gynecotokology, 2016, 8(5):6-8. (in Chinese)
廖运先, 王晨虹. 妊娠期高血压疾病硫酸镁及降压药的应用[J]. 中国计划生育和妇产科, 2016, 8(5):6-8.
[3]Deng L, Fang BM. Clinical epidemiological analysis of hypertensive disorder complicating pregnancy[J]. Hainan Medical Journal, 2015,26(17):2602-2603. (in Chinese)
邓莉, 方碧梅. 妊娠期高血压疾病的临床流行病学分析[J]. 海南医学, 2015,26(17):2602-2603.
[4]Xiang MJ. Analysis of the correlation between the outcome of hypertensive disorder complicating pregnancy and altitude[J]. Tibetan Medicine, 2017,38(1):83-84. (in Chinese)向茂菊.关于妊娠期高血压疾病转归与海拔的相关性分析[J].西藏医药,2017,38(1):83-84.
[5]Chen XY. Clinical analysis of severe preeclampsia in high altitude area[J]. Women’s Health Research,2017,(7):112,116. (in Chinese)
陈秀英.高海拔地区重度子痫前期临床分析[J].中外女性健康研究,2017,(7):112,116.
[6]Gu SQ. Study on the expression of platelet membrane glycoprotein CD62P and CD63 in high altitude hypoxia environment[J]. Journal of High Altitude Medicine,2016,26(1):40-42. (in Chinese)
顾松琴. 高原低氧环境下血小板膜糖蛋白CD62P、CD63表达的研究[J]. 高原医学杂志, 2016,26(1):40-42.
[7]Deng J. Clinical analysis of 70 cases of hypertensive disorder complicating pregnancy in plateau area[J]. Medical Information,2015,(5):59. (in Chinese)
邓军.高原地区妊娠期高血压疾病70例临床分析[J].医学信息,2015,(5):59.
[8]Zhou WT, Hu Y, Xu F, et al. Association of eNOS gene polymorphism with acute mountain sickness and sports hypoxia acclimation[J]. Journal of High Altitude Medicine, 2015, 30(3):72-75. (in Chinese)
周文婷, 胡扬, 徐飞,等. eNOS基因多态性与急性高山病低氧运动习服效果的关联研究[J]. 高原医学杂志, 2015, 30(3):72-75.
[9]Li HR, Zhang YG, Lü CX, et al. Plasma EPO level and T3541G single nucleotide polymorphisms in the 3 ’terminal hypoxic enhancer region of the Han PIH patients in Qinghai Province[J]. Shandong Medical Journal, 2017, 57(19):57-59. (in Chinese)
李红荣, 张耀刚, 吕彩霞,等. 青海省汉族PIH患者血浆EPO水平及EPO基因3’端低氧增强子区T3541G单核苷酸多态性观察[J]. 山东医药, 2017, 57(19):57-59.
[10]Zhang H, Lu C, Fang M, et al. HIF-1α activates hypoxia-induced PFKFB4 expression in human bladder cancer cells.[J]. Biochem Biophys Res Commun, 2016, 476(3):146-152.
[11]Jain A, Kratimenos P, Koutroulis I, et al. Effect of intranasally delivered rh-ⅤEGF165 on angiogenesis following cerebral hypoxia-ischemia in the cerebral cortex of newborn piglets[J]. Int J Mol Sci, 2017, 18(11):2356.
[12]Li HR. Association of eNOS, EPO and TNF-α gene polymorphisms with hypertensive disorder complicating pregnancy in Han population of Qinghai[D]. Qinghai University, 2017. (in Chinese)
李红荣. eNOS、EPO、TNF-α基因多态性与青海省汉族妊娠高血压疾病相关性研究[D]. 青海大学, 2017.
[13] Luizon MR, Sandrim VC, Palei AC, et al. Epistasis among eNOS, MMP-9 and VEGF maternal genotypes in hypertensive disorders of pregnancy[J]. Hypertens Res, 2012, 35(9):917.
[14]Li W. Expression of VEGF and its receptor in placenta of pregnancy induced hypertension syndrome[J]. Cardiovascular Disease Journal of Integrated Traditional Chinese and Western Medicine (Electronic), 2015, 3(35):161. (in Chinese)
李伟. VEGF及其受体在妊娠高血压综合征胎盘的表达[J]. 中西医结合心血管病电子杂志, 2015, 3(35):161.
[15]Hu TX, Jing W, Tan QY, et al. Hydrogen sulfide inhibits high glucose-induced sFlt-1 production via decreasing ADAM17 expression in 3T3-L1 adipocytes[J]. Int J Endocrinol,2017,6(3):1-9.
[16]Semenza GL. A compendium of proteins that interact with HIF-1α[J]. Exp Cell Res, 2017, 35(6):128-135.
[17]Serebrova VN, Trifonova EA, Gabidulina TV, et al. Detection of novel genetic markers of susceptibility to preeclampsia based on an analysis of the regulatory genes in the placental tissue[J]. Mol Biol, 2016, 50(5):870-879.
[18]Kim SY, Park SY, Lim JH, et al. Hypoxia inducible factor-1α gene polymorphisms in Korean patients with pre-eclampsia[J]. J Endocrinol Invest, 2012, 35(7):670-675.
[19]Dellamorte D, Riondino S, Ferroni P, et al. Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity.[J]. Pharmacogenomics, 2015, 16(1):61-78.
[20]Po?arowska D, Po?arowski P. The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy[J]. Cent Eur J Immunol, 2016, 41(3):311-316.
[21]Noushin JN, Farrokh T, Zahra K. Vascular endothelial growth factor expression and vascular density in oral squamous cell carcinoma (OSCC): A study on clinical and histopathologic significance[J]. Med J Islam Repub Iran, 2016, 30(1):358.
[22]Liu L, Bi N, Wu L, et al. MicroRNA-29c functions as a tumor suppressor by targeting VEGFA in lung adenocarcinoma[J]. Mol Cancer, 2017, 16(1):50.
[23]Amosco MD, Villar VAM, Naniong JMA, et al. VEGF-A and VEGFR1 SNPs associate with preeclampsia in a Philippine population[J]. Clin Exp Hypertens, 2016, 38(7):578-585.[24]Andraweera PH, Dekker GA, Dissanavake VH, et al. Vascular endothelial growth factor family gene polymorphisms in preeclampsia in sinhalese woman in Sri-Lanka[J]. Matern Fetal Neonatal Med, 2013, 26(5):532-536.
[25]Chedraui P, Solis EJ, Bocci G, et al. Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia[J]. J Matern Fetal Neonatal Med, 2013, 26(3):226-232.
[26]Amosco MD, Villar VAM, Naniong JMA, et al. VEGF-A and VEGFR1 SNPs associate with preeclampsia in a Philippine population[J]. Clin Exp Hypertens, 2016, 38(7):578-585.[27]Ben AGM, Al-Madhi SA, Zitouni H, et al. Vascular endothelial growth factor single nucleotide polymorphisms and haplotypes in pre-eclampsia: A case-control study[J]. Cytokine, 2017, 97:175-180.
[28]El-Sonbati AZ, El-0Baz RA, Saad EA, et al. Vascular endothelial growth factor VEGF G/C 405 and C/A 2578 gene polymorphisms in cases with pre-eclampsia[J]. Int J Pharm Pharmaceut Sci, 2014, 6(10):281-284.
[29]Wu S, Hao G, Zhang S, et al. Cerebral vasoconstriction reactions and plasma levels of ETBR, ET-1, and eNOS in patients with chronic high altitude disease[J]. Mol Med Reports, 2016, 14(3):2497-2502.
[30]Xia QH. The effect of acute hypoxia at different altitudes on the expression of eNOS gene in rat myocardial tissue[D]. Qinghai University, 2013. (in Chinese)
夏庆华. 不同海拔急性低氧条件对大鼠心肌组织eNOS基因表达的影响[D].青海大学,2013.
[31]Zhang B, Chamba Yangzom, Li QG,et al. Expression of endothelial nitric oxide synthase (eNOS) gene in Tibetan pigs and analysis of hypoxia adaptation[J]. Journal of China Agricultural University, 2013,18(5):104-108. (in Chinese)
张博, 强巴央宗, 李庆岗,等. 藏猪内皮型一氧化氮合酶(eNOS)基因的表达与低氧适应分析[J]. 中国农业大学学报, 2013, 18(5):104-108.
[32]Seremak-Mrozikiewicz A, Drews K, Barlik M, et al. The significance of-786T>C polymorphism of endothelial NO synthase (eNOS) gene in severe preeclampsia[J]. J Matern Fetal Med, 2011, 24(3):432-436.
[33]Leonardo DP, Albuquerque DM, Lanaro C, et al. Association of Nitric Oxide Synthase and Matrix Metalloprotease Single Nucleotide Polymorphisms with Preeclampsia and Its Complications.[J]. PLoS One, 2015, 10(8):e0136693.
[34]Fenstad MH, Johnson MP, Roten LT, et al. Genetic and Molecular Functional Characterization of Variants within TNFSF13B, a Positional Candidate Preeclampsia Susceptibility Gene on 13q[J]. PLoS One, 2010, 5(9):e12993.
|